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1 These authors contributed equally to this work.Helicobacter pylori secretes a unique virulence factor, Tipa, that enters gastric cells and both stim-
ulates the production of the TNF-a and activates the NF-jB pathway. The structures of a truncated
version of Tipa (TipaN34) in two crystal forms are presented here. Tipa adopts a novel b1a1a2b2-
b3a3a4 topology that can be described as a combination of three domains. A ﬁrst region consists
in a short ﬂexible extension, a second displays a dodecin-like fold and a third is a helical bundle
domain similar to the sterile alpha motif (SAM). Analysis of the oligomerisation states of TipaN34
in the crystals and in solution suggests that the disulﬁde bridges could hold together Tipa mono-
mers during their secretion in the gastric environment.
Structured summary:
MINT-7033680: TIP alpha (uniprotkb:B2UTN0) and TIP alpha (uniprotkb:B2UTN0) bind (MI:0407) by
cosedimentation (MI:0027)
 2009 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Helicobacter pylori is a Gram-negative bacterium that colonises
the human stomach. H. pylori is reported as the major cause of sev-
eral gastric pathologies such as gastritis, peptic ulceration, stomach
adenocarcinoma and mucosa-associated lymphoid tissue (MALT)
lymphomas [1]. Virulence factors produced by H. pylori have a piv-
otal role in chronic inﬂammation and increase the risk of cancer
[2,3]. The contribution of major virulence factors produced by H.
pylori to cancer risks has been characterised such as the Cytotoxin
associated gene A protein (CagA), the Vacuolating toxin A (VacA)
and the BabA adhesin (reviewed in [2,4]). A highly immunogenic
H. pylori protein, Tipa (for Tumor necrosis factor a – TNF-a –
inducing protein) was identiﬁed as a new virulence factor activat-
ing NF-jB and inducing the expression of TNF-a, a pro-inﬂamma-
tory cytokine, produced in response to H. pylori infection [5–7].
Tipa also enhances the expression of different chemokines, upreg-
ulates Bcl-2 gene and downregulates p53 gene, thereby contribut-on behalf of the Federation of Euro
tissue; PBP, penicillin bind-
alous dispersion
t).ing to cancer establishment [8,9]. Tipa is present in all H. pylori
genomes sequenced and has been detected in numerous clinical
isolates from patients affected by gastritis, gastroduodenal ulcers
and gastric cancers [6]. The mode of action of Tipa remains elusive
but the protein has been shown to enter gastric cells and possibly
penetrate the nucleus [10]. Tipa sequence displays no similarity to
any known protein but a conserved motif has been proposed be-
tween Tipa and penicillin binding protein (PBP) suggesting that
the protein might adopt a similar fold [11]. The protein is secreted
in the extracellular medium [5,10,12,13] and forms homodimers of
38 kDa held together by inter-subunits disulﬁde bridges involving
C25 and C27 [6]. In vitro, recombinant Tipa can bind both ss- and
dsDNA [14]. A fragment of Tipa starting at residue 28 (delTipa)
showed a considerably reduced ability to induce TNF-a gene
expression, NF-jB activation [6] and to enter gastric cells [10] sug-
gesting an important role for the disulﬁde bridges.
We describe here the crystal structures of a truncated form of
Tipa (TipaN34) in two different crystal forms obtained at pH 4
and pH 8.5. These structures show that Tipa adopts a novel fold,
consisting of an a–b sandwich combined with a helical bundle do-
main. Structural comparison and analysis provides insight into re-
gions that may be involved in protein–protein interactions within
the gastric cells. Gel ﬁltration analysis of the oligomeric state of
Tipa and TipaN34 at different pHs suggests a role for the disulﬁde
bridges during toxin secretion.pean Biochemical Societies.
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A DNA fragment corresponding to the secreted portion of Tipa
(starting at M21) was ampliﬁed from H. pylori genomic DNA and
cloned into pET151/D- topo vector (pET-Tipa). The protein was ex-
pressed in Escherichia coli and puriﬁed with a His-trap column (GE
Healthcare) equilibrated with buffer A (30 mM Tris pH 8, 200 mM
NaCl, 5% glycerol). Tipa was eluted with a linear gradient of imid-
azole from 0 to 500 mM in Buffer A. After tobacco etch virus (TEV)
cleavage, the protein was further puriﬁed by Nickel afﬁnity and
size-exclusion chromatography. Seleno-methionine incorporated
Tipa (SeTipa) was puriﬁed as Tipa except for NaCl concentration,
raised to 500 mM in all buffers. TipaN34 and SeTipaN34 were ob-
tained by incubating respectively Tipa and SeTipawith trypsin at a
protease/protein ratio of 1:1000 (w/w) on ice for 1 h. The vapour
diffusion method was used for crystallisation. Form I crystals were
grown by mixing equal amounts of protein (6 mg/ml) and reservoir
solution containing 100 mM Na Citrate pH 4, 15 mM ATP and from
22% to 28% of Polyethylene glycol (PEG) 4000. Crystals of SeTi-
paN34 grew in 100 mM Na Citrate pH 4, 14% PEG6000 and
15 mM ATP. Crystal form II was obtained by mixing 2 ll of Ti-
paN34 with 2 ll of reservoir solution (100 mM Tris pH 8.5, 26%
PEG4000, 50 mM MgCl2). Data were collected at ESRF beamlines
(Table 1). Native and Se-Met crystal form I diffracted to 1.9 Å and
2.0 Å, respectively, and belonged to the space group P21 with two
molecules per asymmetric unit (Table 1). A highly redundant data-
set was collected at the Se edge with SeTipaN34 crystals. Se sites
were used to obtain experimental phases using the single anoma-Table 1
Data collection, phasing and reﬁnement statistics.
Tip-aN34 Se-Met
pH 4
Tip-aN34 pH 4 Tip-aN34 pH 8.5
Data collection statistics
Beamline ID14-4 ID14-4 ID29
Unit cell (Å)
a 31.64 31.36 48.88
b 102.21 101.99 67.26
c 47.53 47.25 97.47
b 94.40 94.38
Space group P21 P21 P212121
Wavelength (Å) 0.979 0.939 0.981
Resolution limit (Å) 43.0–2.0 50.9–1.9 27.7–1.7
Total observations 151 032
(22 287)*
93 609
(10 799)
128 160
(18 556)
Unique reﬂections 20 350 (2989) 22 965 (3030) 35 854 (5158)
Completeness 99.9 (99.9) 98.4 (90.4) 99.3 (99.6)
Multiplicity 7.4 (7.5) 4.1(3.6) 3.6 (3.6)
hIi/hrIi 7.5 (1.8) 7.6 (2.2) 10.8 (1.9)
Rmerge (%)b 7.4 (40.3) 6.0 (32.5) 4.0 (40.7)
Wilson B-factor (Å2) 24.4 25.2 26.4
Phasing statistics
Se sites 10
FOM (centric/acentric) 0.13/0.41
Anomalous phasing
power
1.74
Reﬁnement statistics
Rcryst 19.6 (27.7) 18.2 (29.3)
Rfree 23.1 (37.7) 21.9 (34.7)
RMS bonds 0.015 0.017
RMS angles 1.482 1.51
Ramachandran outliers Ile52B Ser49A
B-factors
Overall 28.0 17.0
Protein atoms 27.6 15.6
Water atoms 35.0 26.3
Rcryst = (
P
||Fobs  Fcalc||)/(
P
||Fobs||).
* Values in parentheses refer to the highest resolution shell.
b Rmerge =
P
|I  hIi|/|PhIi|.lous dispersion (SAD) method followed by density modiﬁcation
using SHARP [15]. ARP-WARP [16] built an initial model that was
completed manually and reﬁned against the native data using REF-
MAC [17]. Crystal form II diffracted at 1.7 Å and belonged to the
P212121 space group with two molecules per asymmetric unit (Ta-
ble 1). Crystal form II structure was solved by molecular replace-
ment using PHASER [18] and the structure of form I as a search
probe. The coordinates of Tipa crystal forms I and II structures
have been deposited in the PDB, entry codes 2wcq and 2wcr,
respectively. Analytical gel ﬁltration experiments were performed
by injecting 200 lg of Tipa or TipaN34 on a Superdex 75 10/300
column equilibrated in buffer A or in citrate buffer (50 mM citric
acid pH 4, 200 mM NaCl). Details of the methods can be found in
Supplementary data.3. Results and discussion
3.1. Crystal structure of TipaN34 form I
The structure of TipaN34 monomer consists of an elongated,
bean-shaped ab sandwich combined to a helical bundle domain
(Fig. 1A and B). It shows an original b1a1a2b2b3a3a4 topology com-
pleted by a short 310 helix at the N-terminal portion (Fig. 1A and B).
The antiparallel b-sheet formed by b1, b2 and b3 wraps around the
N-terminal half of a1. The C-terminal portion forms a four helix
bundle with a2, a3 and a4, at the top of which lies a long loop con-
necting a1–a2 (Fig. 1B). Differences between the two subunits re-
side essentially at the N-terminal region, which appears more
ﬂexible with L37 to I52 displaying high B-factor values. This exten-
sion together with the bottom part of the b-sheet also mediates in-
ter subunit contacts via hydrophobic interactions between V40,
L45, Y42 and F139 from chain A with V40, M44, L45, F139 from
chain B (Fig. 1C). Those contacts are reinforced by a network of
hydrogen bonds between S58, H60, E137 from both subunits
resulting in a head-to-head dimer related by a pseudo twofold axis
(Fig. 1C and D). However, this dimer interface, burying 814 Å2, is
centred on E137–E137 interactions, contacts that would likely be
unfavoured in solution at a physiological pH.
3.2. Domain organisation and structural similarity with known
proteins
A DALI [19] search identiﬁed more than 500 proteins with Z-
scores lower than 4.3 but none of these structures were larger than
100 residues and no homologue was identiﬁed for the entire Ti-
paN34 structure. Structural homology analysis divides TipaN34
in three parts: a N-terminal loop, consisting of residues N34 to
I52, showing no similarities to existing structures. A second do-
main, consisting of b-strands b1, b2, b3 and the N-terminal half
of a1, is similar to dodecin proteins, in particular to H. salinarum
dodecin (pdb 1mog, rmsd 2.2 Å, 59 residues). Dodecins are small
proteins that oligomerise in dodecamers and bind to FAD [20]. Ti-
paN34 superimposes well with dodecin monomer (Fig. 2A) but the
FAD-binding residues (W36, E45 and Q55) are not conserved. The
third domain consists of the helical bundle, similar to more than
100 proteins with best scores falling into three categories: (i) the
nuclear abundant RNA-binding Nab2 protein (pdb 2v75, rmsd
2.7 Å, 70 residues), (ii) proteins containing the sterile alpha motif
(SAM) domain and (iii) the translation initiation factor 2 alpha,
aIF2 (pdb 1yz6, rmsd 4.8 Å, 90 residues) (Fig. 2B). The helical bun-
dles of Tipa and Nab2 are similar to the PWI fold, a domain found
in several nucleic acid binding proteins [21]. However, the motif
involved in DNA binding in PWI-containing proteins is not con-
served in Tipa nor in Nab2 [21]. More than 20 proteins containing
a SAM domain were also identiﬁed as putative homologues, includ-
Fig. 1. Structure of TipaN34. (A) Topology diagram of TipaN34. (B) Two different views of TipaN34 structure with a-helices in blue, b-strands in red and loops in green. (C)
Ribbon representation of the dimer with chain A and B colored in violet and blue, respectively. (D) Head-to-head dimer interface depicted in ribbon with side chains indicated
as sticks (with carbon atoms colored depending of the subunit, nitrogen in blue, oxygen in red and sulfur in yellow).
Fig. 2. Domain organisation of Tipa structure. (A) Structural superimposition of TipaN34 DOD (grey) with dodecin (green). (B) Comparison of the Tipa SAM domain (grey)
with the structure of Nab2 (orange), SAM domain from polyhomeotic-proximal chromatin protein (blue) and aIF2 (pink). Areas of main divergence are indicated by dashed
boxes. (C) Sequence of Tipa with secondary structures indicated above and colored according to their respective domains (NFE, red; DOD, green and SAM, yellow). The signal
peptide is indicated by a black box, C25 and C27 are colored in red. Starting residues for Tipa and TipaN34 are indicated. (D) Structure of TipaN34 colored according to
domain boundaries.
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Fig. 3. Crystal form II of TipaN34. (A) Superimposition of chain A and chain B showing the different conformations of NFE loop. (B) Two views of the dimer of TipaN34 at pH
8.5 with chain A and B colored in violet and blue, respectively. Dotted boxes points to the three contact sites between subunits. (C) Close-up view of TipaN34 dimer
interaction sites indicated in (A). Side chains of the residues involved are displayed in sticks. (D) Gel ﬁltration analysis of Tipa and TipaN34 at pH 4 and pH 8.5. (E) SDS–PAGE
analysis of the gel ﬁltration experiments at pH 8.5 and pH 4 in the presence or absence of 5 mM b-mercapto-ethanol (b-ME). The arrow indicates Tipa dimer and the
molecular weight markers (MW) sizes are indicated on the right in kDa.
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ephA4 receptor tyrosine kinase. SAM domains are short domains
found in a wide variety of eukaryotic proteins and in few bacterial
ones [21,22]. The structural similarity of Tipa to SAM domain
raises interesting questions since these domains can mediate pro-
tein–protein, protein–DNA and protein–RNA interactions [23]. Ti-
paN34 also resembles domain II of aIF2 (archea) and eIF2
(eukaryotes) but with a high rmsd and a good ﬁt only with a1
(Fig. 2D). Thus, the structure of TipaN34 can be considered as a no-
vel fold containing three regions: a N-terminal ﬂexible extension
(NFE), a dodecin-like domain (DOD) and a SAM-like domain
(SAM) (Fig. 2C and D).3.3. Crystal structure of form II and dimer organisation
The structure of crystal form II monomer is essentially identical
to crystal form I. Major differences are located in the NFE region
that undergoes an important conformational change that swaps
the orientation of the N-terminus. Strand b1 is rotated by 45 and
both b2 and b3 are shifted in the structure at pH 4 compared to
the crystal form I. Noteworthy, this extension adopts very different
conformations in the two chains (Fig. 3A). In chain A, residues from
this loop have their side chains oriented towards the solvent, dis-
connecting the loop from the rest of the molecule and forming a
small solvent channel (Fig. 3A). In chain B, the same side chains,
T. Tosi et al. / FEBS Letters 583 (2009) 1581–1585 1585in particular R48, point towards the concave face of the protein
which changes the orientation of the loop and closes the solvent
channel. The two molecules in the asymmetric unit are arranged
in a different dimer than form I (Figs. 1D and 3B). This arrangement
also generates a pseudo twofold symmetry axis that goes from the
distal N-terminus to the helical bundle burying a total of 1358 Å2
(Fig. 3B). The two subunits are held together by numerous electro-
static and few hydrophobic interactions in three sites (Fig. 3C). At
site 1 the NFEs interact with each other. L37, Q38, D39 and V40 of
chain A interact with V40, D39, Q38 and L37 of Chain B, respec-
tively, to form a highly connected structure (Fig. 3C). At site 2,
the NFEs interact with each other and the NFE from chain A also
contacts b1 of chain B. NFEs interactions include hydrogen bonds
between M44 and Q46 and L45 and Q46. In addition, Q46A side
chain interacts also with W43 of chain B. On one side only, the side
chain of R38 from chain A interacts with D57 from chain B (Fig. 3C).
Site 3 comprises interactions between K91 and E92, L95 and N107,
S96 and E108, and L95 side chains from both chains.
3.4. Oligomeric state of Tipa
To determine the oligomerisation states of Tipa and TipaN34 in
solution, we performed analytical gel ﬁltration experiments
(Fig. 3D). At pH 8.5, both Tipa and TipaN34 eluted at a retention
volume of 10.9 ml, corresponding to a molecular weight of around
30 kDa, in agreement with a theoretical Tipa homodimer. To mi-
mic the form I crystallisation conditions, we performed analytical
gel ﬁltrations at pH 4 and found that TipaN34 eluted at 12 ml, cor-
responding to a monomer. In contrast, Tipa still eluted as a dimer
at around 10.9 ml (Fig. 3D). SDS–PAGE experiments on protein
samples corresponding to the elution peak of the two gel ﬁltration
experiments, conﬁrm that, in absence of reducing agent, Tipa
forms dimers but not TipaN34 (Fig. 3E). This strongly suggests that
crystal form I dimer is likely a crystallisation artefact and that Ti-
paN34 dimer observed in crystal from II at pH 8.5 is more likely
to be relevant in solution.4. Conclusions
Tipa is a unique virulence factor, secreted by all H. pylori strains,
capable of penetrating gastric cells [10]. Our study reveals that this
protein adopts an original fold with no resemblance to known PBPs
as previously suggested. Tipa structure is a combination of three
interconnected regions. These domains point towards putative
protein–protein or protein–nucleic acid interaction sites that could
play important roles in Tipa function. Finally, C25 and C27 were
suggested to be crucial for dimer formation and Tipa activity
[10,14]. We have shown that the two cysteines C25 and C27 are
not necessary for Tipa to form a dimer at pH 8.5. However, at pH
4, their presence seems to be required in solution to hold the
two subunits together. It is possible that in vivo these disulﬁde
bridges could be necessary for keeping Tipa in its dimeric form
when released into the acidic extracellular medium, i.e., the gastric
mucosa.
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